MPT financial statements
The full income statement, balance sheet, and cash-flow statement for Medical Properties Trust Inc. (MPT), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 972M-2.4% | 996M+14.2% | 872M-43.5% | 1.54B-0.1% | 1.54B+23.6% | |
| Cost of revenue | 90.3M+21.8% | 74.2M-32.6% | 110M-34.3% | 167M+65.0% | 101M+236.6% | |
| Selling, general & administrative | 130M-2.5% | 134M-8.1% | 146M-9.3% | 160M+10.2% | 146M+10.6% | |
| General & administrative | 130M-2.5% | 134M-8.1% | 146M-9.3% | 160M+10.2% | 146M+10.6% | |
| Interest expense | 510M+22.1% | 418M+1.6% | 411M+14.5% | 359M-2.3% | 367M+11.8% | |
| Other non-operating income | -173M+72.0% | -616M-8214.5% | 7.59M-50.6% | 15.3M-66.4% | 45.7M+773.8% | |
| Equity-method income | 97.9M+126.7% | -367M-2725.1% | 14.0M-65.8% | 40.8M+43.2% | 28.5M+39.5% | |
| Pre-tax income | -237M+90.0% | -2.36B-244.2% | -687M-171.6% | 960M+31.3% | 731M+57.7% | |
| Income tax | 38.6M-12.4% | 44.1M+133.7% | -131M-333.8% | 55.9M-24.4% | 73.9M+138.1% | |
| -277M+88.5% | -2.41B-333.1% | -556M-161.7% | 903M+37.6% | 656M+52.1% | ||
| Net income to non-controlling interest | 1.11M-44.0% | 1.98M+416.7% | 384K-68.6% | 1.22M+33.0% | 919K+11.8% | |
| -$0.46+88.6% | -$4.02-332.3% | -$0.93-162.0% | $1.50+35.1% | $1.11+37.0% | ||
| EPS (basic) | -$0.46+88.6% | -$4.02-332.3% | -$0.93-162.0% | $1.50+35.1% | $1.11+37.0% | |
| Weighted-avg shares (basic) | 601M+0.1% | 600M+0.3% | 599M-0.0% | 599M+1.7% | 589M+11.3% | |
| Weighted-avg shares (diluted) | 601M+0.1% | 600M+0.3% | 599M-0.1% | 599M+1.5% | 590M+11.3% | |
| Dividends per share | $0.32-30.4% | $0.46-47.7% | $0.88-24.1% | $1.16+3.6% | $1.12+3.7% | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Cash & equivalents | 541M+62.7% | 332M+32.9% | 250M+6.1% | 236M-48.7% | 459M-16.5% | |
| 15.0B+4.9% | 14.3B-21.9% | 18.3B-6.9% | 19.7B-4.2% | 20.5B+21.9% | ||
| Operating lease right-of-use | — | — | — | — | 7.46M-9.4% | |
| 10.4B+9.9% | 9.46B-11.3% | 10.7B-3.5% | 11.1B-8.4% | 12.1B+27.3% | ||
| Long-term debt | 9.70B+9.6% | 8.85B-12.1% | 10.1B-2.0% | 10.3B-9.0% | 11.3B+27.3% | |
| Operating lease liability (total) | 72.0M-8.4% | 78.6M-22.8% | 102M+0.2% | 102M+19.2% | 85.2M-5.3% | |
| Finance lease liability (total) | 1.93M-0.2% | 1.94M-0.1% | 1.94M+0.0% | 1.94M+0.1% | 1.94M+0.1% | |
| 4.61B-4.7% | 4.83B-36.7% | 7.63B-11.2% | 8.59B+1.8% | 8.44B+15.0% | ||
| Preferred stock | — | — | 0.00 | — | — | |
| Common stock | 597K-0.5% | 600K+0.2% | 599K+0.3% | 597K+0.0% | 597K+10.4% | |
| Additional paid-in capital | 8.57B-0.1% | 8.58B+0.3% | 8.56B+0.3% | 8.54B-0.3% | 8.56B+14.8% | |
| Retained earnings | -4.14B-13.1% | -3.66B-276.5% | -972M-935.7% | 116M+232.6% | -87.7M-22.8% | |
| Treasury stock | — | — | — | — | 777K+0.0% | |
| Accumulated other comprehensive income | 168M+278.4% | -94.3M-321.8% | 42.5M+171.8% | -59.2M-61.1% | -36.7M+28.4% | |
| Non-controlling interest | 1.05M+0.0% | 1.05M-53.5% | 2.27M+44.4% | 1.57M-71.4% | 5.48M+3.0% | |
| Total equity incl. non-controlling | 4.61B-4.7% | 4.83B-36.7% | 7.63B-11.2% | 8.59B+1.8% | 8.45B+15.0% | |
| Total liabilities & equity | 15.0B+4.9% | 14.3B-21.9% | 18.3B-6.9% | 19.7B-4.2% | 20.5B+21.9% | |
| Common shares issued | 597M-0.6% | 600M+0.2% | 599M+0.3% | 597M+0.1% | 597M+10.2% | |
| Common shares outstanding | 597M-0.6% | 600M+0.2% | 599M+0.3% | 597M+0.1% | 597M+10.2% | |
| Shares outstanding (cover) | 598M-0.5% | 601M+0.3% | 599M+0.1% | 598M-0.3% | 600M+3.4% | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 231M-6.0% | 245M-51.5% | 506M-31.6% | 739M-9.0% | 812M+31.4% | ||
| Depreciation & amortization | 273M-39.9% | 454M-26.4% | 616M+78.3% | 346M+3.5% | 334M+21.0% | |
| Share-based compensation | 25.7M-21.9% | 33.0M-0.8% | 33.3M-32.7% | 49.4M-5.2% | 52.1M+10.5% | |
| Deferred income taxes | 10.6M-18.2% | 13.0M+108.0% | -163M-656.0% | 29.3M-45.2% | 53.4M+155.4% | |
| -265M-120.1% | 1.32B+154.7% | 518M+30.7% | 396M+110.3% | -3.86B-30.9% | ||
| Capital expenditure | 142M+34.5% | 106M-55.1% | 235M-82.4% | 1.33B-75.1% | 5.35B+25.9% | |
| Free cash flow | 88.7M-36.6% | 140M-48.3% | 271M+145.6% | -594M+86.9% | -4.54B-25.0% | |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 228M+115.4% | -1.48B-45.0% | -1.02B+24.0% | -1.34B-145.5% | 2.95B+110.4% | ||
| Long-term debt issued | 2.51B+212.5% | 804M | 0.00-100.0% | 129M-96.2% | 3.41B+53.8% | |
| Long-term debt repaid | 2.25B+221.0% | 702M-29.0% | 988M+13.6% | 870M-37.5% | 1.39B+73.9% | |
| Common stock issued | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 1.05B+155.7% | |
| Common stock repurchased | 23.4M | 0.00 | 0.00-100.0% | 17.9M | 0.00 | |
| Dividends paid | 193M-39.8% | 321M-47.8% | 615M-11.9% | 699M+8.6% | 643M+13.3% | |
| Other financing activities | -50.6M+60.4% | -128M-1064.1% | 13.3M+124.7% | -53.6M+1.6% | -54.5M-28.7% | |
| FX effect on cash | 14.7M+381.6% | -5.22M-145.8% | 11.4M+188.4% | -12.9M-376.4% | 4.66M-71.6% | |
| Interest paid | 458M+9.0% | 420M+3.5% | 406M+14.8% | 354M+8.4% | 326M+5.3% | |
| Income taxes paid | 20.5M | — | — | — | — | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: MPT’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all MPT filings on SEC EDGAR → Not investment advice.